Company Overview

Network Immunology Inc. is a privately held biotechnology company developing novel immuno-therapies based on immune network theory.

Network Immunology Releases Breakthrough Data from Organ Transplantation Study

Toronto, ON: Network Immunology has received breakthrough data for its platform Co-selection Technology™ that has potential applications to transplantation, autoimmunity and other degenerati..

Network Immunology Completes Private Equity Financing

Vancouver, BC: Network Immunology has completed a financing in partnership with one of the largest wealth management firms in Canada. “We are delighted with this development, as it is a majo..

Network Immunology Announces Data for Entirely Novel Method of HIV Therapy: TheraNet™

Atlanta, GA: Network Immunology reports highly encouraging results have been observed with respect to its HIV therapeutic technology, TheraNet™. In the company’s first study involving ..

Corporate Updates

Captcha Image